We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Cards for NRG Energy's (NRG) Q1 Earnings?
Read MoreHide Full Article
NRG Energy, Inc. (NRG - Free Report) is scheduled to release first-quarter 2020 results on May 7, before the opening bell. The company recorded negative earnings surprise of 5.26% in the last reported quarter.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
NRG Energy provides energy and related services to residential, industrial and commercial customers. Due to the coronavirus outbreak most people are staying back at home. The company’s first-quarter results are likely to reflect benefits from higher residential demand.
Under the transformation plan, the company expects to achieve $80 million of additional margin enhancement in 2020. This is likely to have boosted the company’s first-quarter performance as well.
The Zacks Consensus Estimate for first-quarter earnings per share is pegged at 75 cents, which calls for year-over-year increase of 120.59%.
What Our Quantitative Model Predicts
Our proven model doesn’t conclusively predict an earnings beat for NRG Energy this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here as you will see below. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: The company’s Earnings ESP is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, NRG Energy carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same sector that have the right combination of elements to post an earnings beat this time around.
Spire Inc. (SR - Free Report) is set to release first-quarter 2020 numbers on May 8. It has an Earnings ESP of +0.17% and carries a Zacks Rank #3.
Algonquin Power & Utilities Corp. (AQN - Free Report) is scheduled to release first-quarter 2020 results on May 7. It has an Earnings ESP of +1.59% and a Zacks Rank #2.
Consolidated Edison Inc (ED - Free Report) is scheduled to release first-quarter 2020 results on May 7. It has an Earnings ESP of +0.52% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
What's in the Cards for NRG Energy's (NRG) Q1 Earnings?
NRG Energy, Inc. (NRG - Free Report) is scheduled to release first-quarter 2020 results on May 7, before the opening bell. The company recorded negative earnings surprise of 5.26% in the last reported quarter.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
NRG Energy provides energy and related services to residential, industrial and commercial customers. Due to the coronavirus outbreak most people are staying back at home. The company’s first-quarter results are likely to reflect benefits from higher residential demand.
Under the transformation plan, the company expects to achieve $80 million of additional margin enhancement in 2020. This is likely to have boosted the company’s first-quarter performance as well.
NRG Energy, Inc. Price and EPS Surprise
NRG Energy, Inc. price-eps-surprise | NRG Energy, Inc. Quote
Q1 Expectations
The Zacks Consensus Estimate for first-quarter earnings per share is pegged at 75 cents, which calls for year-over-year increase of 120.59%.
What Our Quantitative Model Predicts
Our proven model doesn’t conclusively predict an earnings beat for NRG Energy this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here as you will see below. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: The company’s Earnings ESP is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, NRG Energy carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same sector that have the right combination of elements to post an earnings beat this time around.
Spire Inc. (SR - Free Report) is set to release first-quarter 2020 numbers on May 8. It has an Earnings ESP of +0.17% and carries a Zacks Rank #3.
Algonquin Power & Utilities Corp. (AQN - Free Report) is scheduled to release first-quarter 2020 results on May 7. It has an Earnings ESP of +1.59% and a Zacks Rank #2.
Consolidated Edison Inc (ED - Free Report) is scheduled to release first-quarter 2020 results on May 7. It has an Earnings ESP of +0.52% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>